RxDoctor Payments Data

Lucy Tasharofi, PA

Medical · Roselle Park, NJNPI 1205087202

Payments from drug & device makers

$1,158in general payments, 2019–2025

Across 41 payments — averaging $28.25 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$594
  • Novo Nordisk$210
  • Amarin Pharma, Inc.$75
  • AbbVie$59
  • Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$56
  • Merck$30
  • plus $133 from 8 others

What the payments were for

  • Food & beverage$1,158100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,158 in reported general payments places this provider in the 65th percentile of 573 medical providers in New Jersey.

See all medical providers in New Jersey

Medicare billing

Part B allowed, 2024
$44,049
Medicare patients
278
Services billed
1,104

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
JanuviaSitagliptin Phosphate21$15,441
PaxlovidNirmatrelvir/Ritonavir16$2,752
Albuterol Sulfate HfaAlbuterol Sulfate47$1,356
Gabapentin16$819
Metoprolol Succinate49$766
Acetazolamide13$686
Lamotrigine12$676
Bupropion XlBupropion Hcl17$523
CefuroximeCefuroxime Axetil36$510
Atorvastatin Calcium59$467
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav50$460
Prednisolone13$415
Lisinopril35$389
Rosuvastatin Calcium24$357
Cefdinir16$344

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
MerckJanuvia$30$15,44121 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 65th percentile of 573 medical providers in New Jersey.

Other medical in Roselle Park

See the full list for New Jersey

Where these figures come from

Is this you, or does something look wrong? →